NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
Back to search
Official data from USPTO
NAMIDA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NAMIDA
ST13
US500000097819600Class
5, 42, 44
Filing
97819600
Registration
7673580
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/28/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/02/2023
Registration date
01/28/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
01/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
Fayetteville, AR, US
Examiner
THOMA, GABRIELLE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Namida Lab, Inc.
Representatives
Ryan D. Artis RIVERSIDE LAW LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic test kits consisting primarily of medical diagnostic immunoassays and complement diagnostic reagents for testing of human diseases, namely, breast cancer, for clinical medical testing and medical use
Class 42
Biotechnology research and development; Medical research and development; Scientific research and development; Medical and scientific research services in the field of diagnostic tests for cancer, inflammatory diseases, and psychological maladies; Medical laboratories
Class 44
Providing medical screening services for cancer and inflammatory diseases, and psychological maladies; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening using protein biomarkers; Medical screening using RNA and DNA biomarkers; Medical screening service in the field of tear testing for breast health screening
Publications
History of USPTO decisions and trademark events.
24 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/28/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/01/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/01/2024
GNRT
NON-FINAL ACTION E-MAILED
07/01/2024
CNRT
NON-FINAL ACTION WRITTEN
07/01/2024
IUAA
USE AMENDMENT ACCEPTED
07/01/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/12/2024
IUAF
USE AMENDMENT FILED
04/12/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/01/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2023
GNRT
NON-FINAL ACTION E-MAILED
12/01/2023
CNRT
NON-FINAL ACTION WRITTEN
12/01/2023
DOCK
ASSIGNED TO EXAMINER
11/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/22/2023
NWAP
NEW APPLICATION ENTERED
03/06/2023
Continuous trademark protection
Get notified about every new filing that threatens NAMIDA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.